153 related articles for article (PubMed ID: 31714507)
21. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases.
Demirci H; Shields CL; Karatza EC; Shields JA
Ophthalmology; 2008 Sep; 115(9):1626-31, 1631.e1-3. PubMed ID: 18440641
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.
Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J
Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma.
Nam H; Ahn YC; Kim YD; Ko Y; Kim WS
Radiother Oncol; 2009 Feb; 90(2):236-41. PubMed ID: 18950885
[TBL] [Abstract][Full Text] [Related]
24. Orbital MALT lymphoma, abdominal hodgkin lymphoma, and systemic diffuse large B-cell lymphoma develop sequentially in one patient.
Matsuo T; Ichimura K; Shinagawa K
J Clin Exp Hematop; 2012; 52(1):41-9. PubMed ID: 22706530
[TBL] [Abstract][Full Text] [Related]
25. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
[TBL] [Abstract][Full Text] [Related]
26. A correlation study between IgH gene rearrangement and orbital lymphoma removal operation prognosis.
Ding B; Ju ZC; Liu JM
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2561-2566. PubMed ID: 28678330
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
28. [The progress in the diagnosis and management of orbital lymphoma].
Shi YY; Jia RB; Fan XQ
Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):632-636. PubMed ID: 28851203
[TBL] [Abstract][Full Text] [Related]
29. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
Skacel M; Ross CW; Hsi ED
Histopathology; 2000 Jul; 37(1):10-8. PubMed ID: 10931213
[TBL] [Abstract][Full Text] [Related]
30. Mucosa-associated lymphoid tissue lymphoma with intraocular and orbital involvement: case presentation and review of the literature.
Freedman K; Shenoy S
Orbit; 2018 Aug; 37(4):243-247. PubMed ID: 29027822
[TBL] [Abstract][Full Text] [Related]
31. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
32. Typical genomic imbalances in primary MALT lymphoma of the orbit.
Matteucci C; Galieni P; Leoncini L; Lazzi S; Lauria F; Polito E; Martelli MF; Mecucci C
J Pathol; 2003 Aug; 200(5):656-60. PubMed ID: 12898603
[TBL] [Abstract][Full Text] [Related]
33. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies in the diagnosis of lymphoproliferative diseases of the orbit and orbital adnexae.
Norton AJ
Eye (Lond); 2006 Oct; 20(10):1186-8. PubMed ID: 17019417
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis and therapy of lymphoid tumors of the orbits].
Issing PR; Ruh S; Kloss A; Kuske M; Lenarz T
HNO; 1997 Jul; 45(7):545-50. PubMed ID: 9340337
[TBL] [Abstract][Full Text] [Related]
36. [Lymphoproliferative diseases of the orbit and appendages of the eye].
Nechesniuk SIu; Probatova NA; Grishina EE; Kovrigina AM; Tupitsyn NN; Sholokhova EN
Arkh Patol; 2001; 63(1):27-32. PubMed ID: 11242851
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic profiles for distinguishing orbital mucosa-associated lymphoid tissue lymphoma from benign lymphoproliferative tumors.
Ueda S; Usui Y; Nagai T; Diaz-Aguilar D; Nagao T; Goto H
Jpn J Ophthalmol; 2017 Jul; 61(4):354-360. PubMed ID: 28421369
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic difficulties and treatment of non-Hodgkin lymphoma of the orbit.
Wanyura H; Uliasz M; Kaminski A; Samolczyk-Wanyura D; Smolarz-Wojnowska A
J Craniomaxillofac Surg; 2007 Jan; 35(1):39-47. PubMed ID: 17267230
[TBL] [Abstract][Full Text] [Related]
39. Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases.
Bates AW; Norton AJ; Baithun SI
J Clin Pathol; 2000 Jun; 53(6):458-61. PubMed ID: 10911804
[TBL] [Abstract][Full Text] [Related]
40. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
Goda JS; Le LW; Lapperriere NJ; Millar BA; Payne D; Gospodarowicz MK; Wells W; Hodgson DC; Sun A; Simpson R; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e659-66. PubMed ID: 21640514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
